Gout: tophaceous lesion of the spine
https://doi.org/10.24884/1609-2201-2025-104-3-44-50
Abstract
This article is a review of published clinical cases of tophaceous lesions of the musculoskeletal system. Tophaceous lesions of organs and tissues are more common in long-term gout, but sometimes they can be the first manifestation of the disease. The aim is to systematize the data presented in the literature on clinical cases of tophaceous lesions of the musculoskeletal system. Materials and methods: review of literature on the presented clinical cases. Results: tophi may occur in various structures of the musculoskeletal system with the development of non-specific symptoms of varying severity depending on the level and volume of the lesion. Conclusion: tophaceous lesions of the musculoskeletal system should be considered in patients with corresponding complaints and an existing diagnosis of gout or the presence of hyperuricemia.
About the Authors
I. I. Nesterovich
Pavlov University
Russian Federation
Russian Federation
Irina I. Nesterovich, Dr. of Sci. (Med.), professor of the Department of Hospital Therapy with a course of Allergology and Immunology named after acad. M. V. Chernorutsky with a clinic
Saint Petersburg
M. A. Melnikova
Pavlov University
Russian Federation
Russian Federation
Mariia A. Melnikova, II year resident in therapy specialty
6-8, L’va Tolstogo str., Saint Petersburg, 197022
References
1. Idiopathic gout. Clinical recommendations. The Association of Rheumatologists of Russia. 2025. (In Russ.).
2. Del Pinto R., Viazzi F., Pontremoli R. et al. The URRAH study. Panminerva Med. 2021;63(4):416–423. https://doi.org/10.23736/S0031-0808.21.04357-3.
3. Ruocco G., Palazzuoli A. Hyperuricemia in US Population with Heart Failure: Causal or Incidental Bystander? Cardiorenal Med. 2019;9(6):341–343. https://doi.org/10.1159/000503058.
4. Musaeva N. Z., Oshchepkova E. V., Aksenova A. V. et al. Connection between uric acid and cardiovascular risk factors in hypertensive patients. Systemic Hypertension. 2023;20(3):19–25. (In Russ.). https://doi.org/10.38109/2075-082X-2023-3-19-25.
5. Bruchkus E. A., Kulik V. V., Kirpichnikov S. I., Shaporova N. L. Uric acid level as a risk factor for the adverse course of COPD and acute coronary syndrome (ACS). New St. Petersburg Medical Records. 2024;(4):20–25. (In Russ.). https://doi.org/10.24884/1609-2201-2024103-4-20-25.
6. Eliseev M. S. Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2018;12(1):60–65. https://doi.org/10.14412/1996-7012-2018-1-60-65.
7. Kunitskaya N. A., Ariev A. L., Kulaeva N. N. The role of uric acid in the development of inflammation in kidney disease. Nephrology (Saint Petersburg). 2023;27(2):39–46. (In Russ.). https://doi.org/10.36485/1561-6274-2023-27-2-39-46.
8. Drapkina O. M., Mazurov V. I., Martynov A. I. et al. Consensus statement on the management of patients with asymptomatic hyperuricemia in general medical practice. Cardiovascular Therapy and Prevention. 2024;23(1):3737. (In Russ.). https://doi.org/10.15829/1728-8800-2024-3737.
9. Bashkinov R. A., Mazurov V. I., Gaydukova I. Z. et al. Features of the course of osteoarthritis in patients with asymptomatic hyperuricemia. Terapiya = Therapy. 2025;83(1):16–28. (In Russ.). https://doi.org/10.18565/therapy.2025.1.16-28.
10. Mazurov V. I., Bashkinov R. A., Fonturenko A. Yu. et al. Features of the course of rheumatoid arthritis and osteoarthritis in patients with asymptomatic hyperuricemia. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I. I. Mechnikova = Herald of the Northwestern State Medical University named after I. I. Mechnikov. 2020;12(3):63–72. (In Russ.). https://doi.org/10.17816/mechnikov44234.
11. Gaydukova I. Z., Mazurov V. I., Inamova O. V., Petrova M. S. Hyperuricemia effect on clinical and immunological aspects of psoriatic arthritis. Russian Medical Inquiry. 2025;9(3):156–161. (In Russ.). https://doi.org/10.32364/2587-6821-2025-9-3-2.
12. Musiychuk M. M., Gaydukova I. Z., Mazurov V. I. et al. Impact of hyperuricemia at the clinical course of systemic lupus erythematosus and comorbid conditions in young and middle-aged female patients. Terapiya = Therapy. 2025;83(1):37–46. (In Russ.). https://doi.org/10.18565/therapy.2025.1.37-46.
13. Kersley G. D., Mandel L., Jeffrey M. R. Gout; an unusual case with softening and subluxation of the first cervical vertebra and splenomegaly. Ann Rheum Dis. 1950;9(4):282–304. https://doi.org/10.1136/ard.9.4.282.
14. Harlianto N. I., Harlianto Z. N. Patient characteristics, surgical treatment, and outcomes in spinal gout: a systematic review of 315 cases. Eur Spine J. 2023;32:3697–3703. https://doi.org/10.1007/s00586-023-07942-8.
15. Nazwar T. A., Bal’afif F., Wardhana D. W., Panjaitan C. Understanding spinal gout: A comprehensive study of 88 cases and their clinical implications. J Craniovertebr Junction Spine. 2024;15(2):133–140. https://doi.org/10.4103/jcvjs.jcvjs_166_23.
16. Eliseev M. S. Gouty lesions in the spine. RMJ. Rheumatology. 2016;(2):89. (In Russ.).
17. Eliseev M. S., Mukagova M. V., Smirnov A. V. et al. Atypical gout: spinal tophaceous injury. Rheumatology Science and Practice. 2013;51(5):586–589. (In Russ.). https://doi.org/10.14412/1995-44842013-1553.
18. Sorotskaya V. N., Eliseev M. S. Gout with tophus mimicking a tumor of the thoracic spine. Rheumatology Science and Practice. 2018;56(1):113–116. (In Russ.). https://doi.org/10.14412/1995-44842018-113-116.
19. Kuzmina Y. I., Eliseev M. S. Spinal involvement in gout simulating spondyloarthritis (clinical case). Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2024;18(1):90–94. (In Russ.). https://doi.org/10.14412/1996-7012-2024-1-90-94.
20. Zhang W., Feng Q., Gu J., Liu H. Carpal tunnel syndrome caused by tophi deposited under the epineurium of the median nerve: A case report. Front Surg. 2023;9:942062. https://doi.org/10.3389/ fsurg.2022.942062.
21. Kulakov D. Y., Lyalina V. V., Skripnichenko E. A. et al. Tophaceous Gout Causing the Carpal Tunnel Syndrome and Flexor Digitorum Dysfunction: A Case Report. The Russian Archives of Internal Medicine. 2021;11(2):154–160. (In Russ.). https://doi.org/10.20514/2226-67042021-11-2-154-160.
22. Kim H. S. Carpal tunnel syndrome caused by tophaceous gout. Korean J Intern Med. 2014;29(4):544–5. https://doi.org/10.3904/kjim.2014.29.4.544.
23. Hao H., Kong W., Li H. Carpal tunnel syndrome caused by tophi in the superficial flexor tendon: a case report. Front. Surg. 2023;10:1282202. https://doi.org/10.3389/fsurg.2023.1282202.
24. Nakamichi K., Tachibana S. Cubital tunnel syndrome caused by tophaceous gout. The Journal of Hand Surgery: British & European Volume. 1996;21(4):559–560. https://doi.org/10.1016/S0266-7681(96)800660.
25. Resorlu H., Zateri C., Akbal A. et al. Cubital tunnel syndrome secondary to gouty tophi: A case report. J Pak Med Assoc. 2017;67(3):474– 475.
26. Lui T. H. Acute Posterior Tarsal Tunnel Syndrome Caused by Gouty Tophus. Foot Ankle Spec. 2015;8(4):320–3. https://doi.org/10.1177/1938640014548318.
27. Doucet V., McLeod G. J., Petropolis C. J. Gouty Stenosing Tenosynovitis: Trigger Finger as a First Presentation of Tophaceous Gout. Plast Reconstr Surg Glob Open. 2020;8(8):e3055. https://doi.org/10.1097/GOX.0000000000003055.
28. Prescher H., Teven C. M., Shenaq D., Reavey P. L. Gouty flexor tenosynovitis – Case report and review of the literature. J Clin Images Med Case Rep. 2021;2(3):1160.
29. Lee D. Y., Eo S., Lim S., Yoon J. S. Gouty tenosynovitis with compartment syndrome in the hand: A case report. World J Clin Cases. 2023;11(30):7492–7496. https://doi.org/10.12998/wjcc.v11.i30.7492.
30. Chou H., Chin T. Y., Peh W. C. Dual-energy CT in gout - A review of current concepts and applications. J Med Radiat Sci. 2017;64(1):41–51. https://doi.org/10.1002/jmrs.223.
31. Soon B., Sia D., Zhang J. Spinal Gout—Dual-Energy CT for Noninvasive Diagnosis. JCR: Journal of Clinical Rheumatology. 2018;26(4):e87–e88. https://doi.org/10.1097/00124743-90000000099149.
Review
For citations:
Nesterovich I.I., Melnikova M.A. Gout: tophaceous lesion of the spine. New St. Petersburg Medical Records. 2025;(3):44-50. (In Russ.) https://doi.org/10.24884/1609-2201-2025-104-3-44-50
Views:
46
Email this article 